|
1.
|
|
7 p, 227.7 KB |
Delayed antibiotic prescribing for respiratory tract infections : Protocol of an individual patient data meta-analysis
/
Stuart, Beth (University of Southampton) ;
Hounkpatin, Hilda (University of Southampton) ;
Becque, Taeko (University of Southampton) ;
Yao, Guiqing (University of Leicester) ;
Zhu, Shihua (University of Southampton) ;
Alonso-Coello, Pablo (Institut d'Investigació Biomèdica Sant Pau) ;
Altiner, Attila (University of Rostock) ;
Arroll, Bruce (University of Auckland) ;
Böhning, Dankmar (University of Southampton) ;
Bostock, Jennifer (King's College London) ;
Bucher, Heiner (University of Basel) ;
De La Poza, Mariam (Institut Català de la Salut) ;
Francis, Nick A. (Cardiff University) ;
Gillespie, David (Cardiff University) ;
Hay, Alastair D. (University of Bristol) ;
Kenealy, Timothy (University of Auckland) ;
Löffler, Christin (Rostock University Medical Center) ;
Mas Dalmau, Gemma (Institut d'Investigació Biomèdica Sant Pau) ;
Muñoz, Laura (Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)) ;
Samuel, Kirsty (University of Leeds) ;
Moore, Michael (University of Southampton) ;
Little, Paul (University of Southampton) ;
Universitat Autònoma de Barcelona
Delayed prescribing can be a useful strategy to reduce antibiotic prescribing, but it is not clear for whom delayed prescribing might be effective. This protocol outlines an individual patient data (IPD) meta-analysis of randomised controlled trials (RCTs) and observational cohort studies to explore the overall effect of delayed prescribing and identify key patient characteristics that are associated with efficacy of delayed prescribing. [...]
2019 -  10.1136/bmjopen-2018-026925
BMJ open, Vol. 9 Núm. 1 (january 2019) , p. e026925
|
|
|
2.
|
|
12 p, 2.2 MB |
Cost-effectiveness of midostaurin in the treatment of acute myeloid leukemia with the FLT3 mutation in Spain
/
Arenaza, Ainhoa (Clínico San Carlos Hospital) ;
Diez, Raúl (Hospital Universitario de Getafe (Madrid)) ;
Esteve Reyner, Jordi (Hospital Clínic i Provincial de Barcelona) ;
Di Nicolantonio, Roberta (Novartis Farmacéutica S.A) ;
Gostkorzewicz, Joana (Novartis Farmacéutica S.A) ;
Martínez, Carlos (Arabako Unibertsitate Ospitalea (Vitoria, País Basc)) ;
Martínez Llinàs, Diana (Oblikue Consulting. S.L) ;
Martínez-López, Joaquín (Hospital 12 de Octubre (Madrid)) ;
Montesinos, Pau (Hospital Universitari i Politècnic La Fe (València)) ;
Moure-Fernández, Aída (Oblikue Consulting. S.L) ;
Sierra, Jorge (Institut d'Investigació Biomèdica Sant Pau) ;
Vinent, Joan Lluís (Hospital Sant Joan de Déu (Manresa)) ;
Universitat Autònoma de Barcelona
The addition of midostaurin to standard chemotherapy (cytarabine and daunorubicin) has shown significant improvements in the survival of patients with acute myeloid leukemia with the FLT3 mutation (FLT3-AML). [...]
2019 - 10.2147/CEOR.S222879
ClinicoEconomics and outcomes research, Vol. 11 (2019) , p. 683-694
|
|
|
3.
|
|
22 p, 774.7 KB |
Economic Evaluation of Clinical, Nutritional and Rehabilitation Interventions on Oropharyngeal Dysphagia after Stroke : A Systematic Review
/
Marin, Sergio (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Ortega, Omar (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Serra-Prat, Mateu (Hospital de Mataró. Consorci Sanitari del Maresme) ;
Valls, Ester (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Pérez-Cordón, Laia (Hospital de Mataró. Consorci Sanitari del Maresme) ;
Clavé i Civit, Pere (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Universitat Autònoma de Barcelona
Background: Post-stroke oropharyngeal dysphagia (PS-OD) and its complications increase healthcare costs, suggesting that its appropriate management is cost-effective. We aimed to assess the efficiency of healthcare interventions in PS-OD management. [...]
2023 - 10.3390/nu15071714
Nutrients, Vol. 15 (march 2023)
|
|
|
4.
|
|
17 p, 483.0 KB |
La Transición Alimentaria en México : causas económicas y consecuencias para la salud humana y ambiental
/
Peniche Camps, Salvador (Universidad de Guadalajara. Departamento de Economía) ;
Chávez Gómez, Pedro (Consejo Nacional de Ciencia y Tecnología (Mèxic))
La emergencia sanitaria causada por la infección del virus SARS-CoV-2 puso en evidencia una realidad que fue gestándose por décadas en el país y en muchas regiones del mundo: las consecuencias para la salud de un modelo alimentario basado en la lógica del mercado. [...]
The health emergency caused by the SARS-CoV-2 virus infection highlighted a reality that had been brewing for decades in the country and in many regions of the world: the health consequences of a food model based on market logic. [...]
A emergência sanitária causada pela infecção pelo vírus SARS-CoV-2 revelou uma realidade que se fermentava há décadas no país e em várias regiões do mundo: as consequências para a saúde de um modelo alimentar baseado na lógica de mercado. [...]
The health emergency caused by the SARS-CoV-2 virus infection highlighted a reality that had been brewing for decades in the country and in many regions of the world: the health consequences of a food model based on market logic. [...]
2022
Revibec : revista de la Red Iberoamericana de Economia Ecológica, Vol. 35 Núm. 2 (2022) , p. 20-36 (Articles)
|
|
|
5.
|
|
11 p, 472.3 KB |
Study protocol for a randomised, double-blinded, placebo-controlled phase III trial examining the add-on efficacy, cost-utility and neurobiological effects of low-dose naltrexone (LDN) in patients with fibromyalgia (INNOVA study)
/
Colomer-Carbonell, Ariadna (Universitat Autònoma de Barcelona. Departament de Psicologia Bàsica, Evolutiva i de l'Educació) ;
Sanabria-Mazo, Juan P.. (Universitat Autònoma de Barcelona. Departament de Psicologia Bàsica, Evolutiva i de l'Educació) ;
Hernández-Negrín, Halbert (Universitat Autònoma de Barcelona. Departament de Psicologia Bàsica, Evolutiva i de l'Educació) ;
Borràs, Xavier (Universitat Autònoma de Barcelona. Departament de Psicologia Bàsica, Evolutiva i de l'Educació) ;
Suso-Ribera, Carlos (Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición) ;
García-Palacios, Azucena (Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición) ;
Muchart, Jordi (Hospital Sant Joan de Déu (Manresa)) ;
Munuera, Josep (Hospital Sant Joan de Déu (Manresa)) ;
D'Amico, Francesco (London School of Economics and Political Science) ;
Maes, Michael (Chulalongkorn University) ;
Younger, Jarred W. (University of Alabama at Birmingham) ;
Feliu-Soler, Albert (Universitat Autònoma de Barcelona. Departament de Psicologia Clínica i de la Salut) ;
Rozadilla-Sacanell, Antoni (Parc Sanitari Sant Joan de Déu) ;
Luciano, Juan V. (Universitat Autònoma de Barcelona. Departament de Psicologia Clínica i de la Salut)
There is evidence that low-dose naltrexone (LDN; <5. 0 mg/day) reduces pain and improves the quality of life of people with fibromyalgia syndrome (FMS). However, no randomised controlled trials with long-term follow-ups have been carried out. [...]
2022 - 10.1136/bmjopen-2021-055351
BMJ open, Vol. 12 (January 2022) , art. e055351
|
|
|
6.
|
|
12 p, 1.5 MB |
Decision Analysis in SHared decision making for Thromboprophylaxis during Pregnancy (DASH-TOP) : a sequential explanatory mixed methods pilot study protocol
/
Humphries, Brittany (McMaster University (Canadà)) ;
León-García, Montserrat (Universitat Autònoma de Barcelona. Departament de Pediatria, Obstetrícia i Ginecologia i Medicina Preventiva i Salut Pública) ;
Bates, Shannon (McMaster University (Canadà)) ;
Guyatt, Gordon (McMaster University (Canadà)) ;
Eckman, Mark (University of Cincinnati) ;
D'Souza, Rohan (University of Toronto) ;
Shehata, Nadine (Mount Sinai Hospital (Toronto, Canadà)) ;
Jack, Susan (McMaster University (Canadà)) ;
Alonso-Coello, Pablo (Institut d'Investigació Biomèdica Sant Pau) ;
Xie, Feng (McMaster University (Canadà))
Decision analysis is a quantitative approach to decision making that could bridge the gap between decisions based solely on evidence and the unique values and preferences of individual patients, a feature especially important when existing evidence cannot support clear recommendations and there is a close balance between harms and benefits for the treatments options under consideration. [...]
2021 - 10.1136/bmjopen-2020-046021
BMJ open, Vol. 11 (march 2021)
|
|
|
7.
|
|
8 p, 1.5 MB |
Comparing the effectiveness and cost-effectiveness of self-management interventions in four high-priority chronic conditions in Europe (COMPAR-EU) : a research protocol
/
Ballester, Marta (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Orrego, Carola (Universitat Autònoma de Barcelona. Institut Universitari Avedis Donabedian) ;
Heijmans, Monique (Netherlands Institute for Health Services Research (NIVEL)) ;
Alonso-Coello, Pablo (Institut d'Investigació Biomèdica Sant Pau) ;
Versteegh, Matthijs Michaël (Erasmus University Rotterdam) ;
Mavridis, Dimitri (Universite Paris Descartes Faculte de Medecine) ;
Groene, Oliver (OptiMedis AG) ;
Immonen, Kaisa (European Patients' Forum) ;
Wagner, Cordula (Netherlands Institute for Health Services Research (NIVEL)) ;
Canelo Aybar, Carlos Gilberto (Institut d'Investigació Biomèdica Sant Pau) ;
Suñol Sala, Rosa (Universitat Autònoma de Barcelona. Institut Universitari Avedis Donabedian)
Population ageing and increasing chronic illness burden have sparked interest in innovative care models. While self-management interventions (SMIs) are drawing increasing attention, evidence of their efficacy is mostly based on pairwise meta-analysis, generally derived from randomised controlled trials comparing interventions versus a control or no intervention. [...]
2020 - 10.1136/bmjopen-2019-034680
BMJ open, Vol. 10 (january 2020)
|
|
|
8.
|
|
7 p, 434.6 KB |
SCOT : a comparison of cost-effectiveness from a large randomised phase III trial of two durations of adjuvant Oxaliplatin combination chemotherapy for colorectal cancer
/
Robles-Zurita, José (University of Glasgow. Institute of Health and Wellbeing) ;
Boyd, Kathleen A. (University of Glasgow. Institute of Health and Wellbeing) ;
Briggs, Andrew H. (University of Glasgow. Institute of Health and Wellbeing) ;
Iveson, Timothy (University Hospital Southampton NHS Foundation Trust (Regne Unit)) ;
Kerr, Rachel S. (University of Oxford. Department of Oncology) ;
Saunders, Mark P. (The Christie Hospital) ;
Cassidy, Jim (University of Glasgow. Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences) ;
Hollander, Niels Henrik (Zealand University Hospital) ;
Tabernero, Josep (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Segelov, Eva (Australasian Gastro-Intestinal Trials Group (AGITG) and Monash University and Monash Health) ;
Glimelius, Bengt (University of Uppsala) ;
Harkin, Andrea (University of Glasgow. Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences) ;
Allan, Karen (University of Glasgow. Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences) ;
McQueen, John (University of Glasgow. Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences) ;
Pearson, Sarah (University of Oxford. Department of Oncology, OCTO) ;
Waterston, Ashita (Beatson West of Scotland Cancer Centre (Glasgow, Regne Unit)) ;
Medley, Louise (Royal United Hospital) ;
Wilson, Charles (Addenbrookes Hospital (Cambridge, Regne Unit)) ;
Ellis, Richard (Royal Cornwall Hospitals NHS Trust) ;
Essapen, Sharadah (St Luke's Cancer Centre, Royal Surrey County Hospital NHS Foundation Trust) ;
Dhadda, Amandeep S. (Castle Hill Hospital) ;
Hughes, Rob (Mount Vernon Cancer Centre) ;
Falk, Stephen (Bristol Cancer Institute, Bristol, UK) ;
Raouf, Sherif (Barking Havering and Redbridge University Hospital NHS Trust, Barking, UK) ;
Rees, Charlotte (University Hospital Southampton NHS Foundation Trust (Regne Unit)) ;
Olesen, Rene K. (Zealand University Hospital) ;
Propper, David (Barts Cancer Institute (BCI)) ;
Bridgewater, John (University College London) ;
Azzabi, Ashraf (Newcastle upon Tyne Hospitals NHS Foundation Trust) ;
Farrugia, David (Gloucestershire Oncology Centre, Cheltenham General Hospital) ;
Webb, Andrew (Brighton and Sussex University Hospital Trust) ;
Cunningham, David (Royal Marsden (funded by NIHR BRC at the Royal Marsden)) ;
Hickish, Tamas (Poole Hospital/Bournemouth University) ;
Weaver, Andrew (Churchill Hospital, Oxford University Hospitals Foundation Trust) ;
Gollins, Simon (North Wales Cancer Treatment Centre, Rhyl, UK) ;
Wasan, Harpreet S.. (Hammersmith Hospital (Londres)) ;
Paul, James (University of Glasgow. Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences)
The Short Course Oncology Therapy (SCOT) study is an international, multicentre, non-inferiority randomised controlled trial assessing the efficacy, toxicity, and cost-effectiveness of 3 months (3 M) versus the usually given 6 months (6 M) of adjuvant chemotherapy in colorectal cancer. [...]
2018 - 10.1038/s41416-018-0319-z
British Journal of Cancer, Vol. 119 (november 2018) , p. 1332-1338
|
|
|
9.
|
|
|
10.
|
|
10 p, 517.0 KB |
Impact of hip fracture on hospital care costs : a population-based study
/
Leal, José (University of Oxford. Nuffield Department of Population Health) ;
Gray, A. M. (University of Oxford. Nuffield Department of Population Health) ;
Prieto-Alhambra, Daniel (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Arden, N. K. (University Hospital Southampton NHS Foundation Trust (Regne Unit)) ;
Cooper, Cyrus (University Hospital Southampton NHS Foundation Trust (Regne Unit)) ;
Javaid, M. K. (University Hospital Southampton NHS Foundation Trust (Regne Unit)) ;
Judge, Andrew (University Hospital Southampton NHS Foundation Trust (Regne Unit)) ;
Universitat Autònoma de Barcelona
Using a large cohort of hip fracture patients, we estimated hospital costs to be £14,163 and £2139 in the first and second year following fracture, respectively. Second hip and non-hip fractures were major cost drivers. [...]
2015 - 10.1007/s00198-015-3277-9
Osteoporosis International, Vol. 27 (august 2015) , p. 549-558
|
|
visitant ::
identificació
alerta personal via correu electrònic o subscribiu-vos al 
canal RSS.
